Efficacy and safety of mometasone furoate vs nedocromil sodium as prophylactic treatment for moderate/severe seasonal allergic rhinitis

Annals of Allergy, Asthma and Immunology

Volumn 96, Issue 5, 2006, Pages 673-678

  Pitsios, Constantinos ^a   Papadopoulos, Dimitrios ^b   Kompoti, Evangelia ^a   Manoussakis, Emmanouel ^c   Garris, Viktor ^c   Petalas, Konstantinos ^a   Tassios, Ioannis ^c   Baibas, Nikolaos ^c   Kontou Fili, Kalliopi ^a   Saxoni Papageorgiou, Photini ^c   Papadopoulos, Nikolaos G ^c  

^a LAIKO GENERAL HOSPITAL   (Greece)

^b 424 General Army Hospital   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

MOMETASONE FUROATE; NEDOCROMIL SODIUM;

ADOLESCENT; ADULT; APPLICATION SITE BURNING; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EPISTAXIS; FEMALE; FEVER; GRASS POLLEN; HAY FEVER; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; OLIVE; OPEN STUDY; PARIETARIA; PATIENT SATISFACTION; POLLEN ALLERGY; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SOMNOLENCE; TASTE DISORDER;

EID: 33646728948     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61064-2     Document Type: Article

References (26)

1. Bousquet J, van Cauwenberge P, Khaltaev N; ARIA Workshop Group and World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108: S147-S334.
2. ISAAC Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet. 1998;351:1225-1232.
3. Grigoreas C, Vourdas D. Increasing prevalence of seasonal allergic rhinitis among Greek Air-Force officers. Hell Al Clin Immunol. 1999;7:43-50.
4. Kontou-Fili K. Seasonal pattern of airborne inhalant allergens in Athens, Greece. Allergy Clin Immunol News. 1995;7:136-140.
5. Demesticha Z, Roumana A, Economides A, et al. Aeroallergen sensitization in Hellenic patients with respiratory allergy. Allergy. 1999;54:S106.
6. LaForce C. Use of nasal steroids in managing allergic rhinitis. J Allergy Clin Immunol. 1999;103:S388-S394.
7. Lumry WR. A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis. J Allergy Clin Immunol. 1999;104:S150-S158.
8. Mygind N, Nielsen LP, Hoffmann HJ, et al. Mode of action of intranasal corticosteroids. J Allergy Clin Immunol. 2001;180: S16-S25.
9. Corren J. Intranasal corticosteroids for allergic rhinitis: how do different agents compare? J Allergy Clin Immunol. 1999;104: S144-S149.
10. Cervin A, Andersson M. Intranasal and septum perforation: an overlooked complication? A description of the course of events and a discussion of the causes. Rhinology. 1998;36:128-132.
11. Minshall E, Ghaffar O, Cameron L, et al. Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis. Otolaryngol Head Neck Surg. 1998;118:648-654.
12. Holm AF, Fokkens WJ, Godhelp T, et al. A 1-year placebo-controlled study of intranasal fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis: a safety and biopsy study. Clin Otolaryngol. 1998;23:69-73.
13. Brannan MD, Herron JM, Affrime MB. Safety ad tolerability of once-daily mometasone furoate aqueous nasal spray in children. Clin Ther. 1997;19:1330-1339.
14. Wilson AM, McFarlane LC, Lipworth BJ. Effects of repeated once-daily dosing of three intranasal corticosteroids on basal and dynamic measures of hypothalamic-pituitary-adrenal axis activity. J Allergy Clin Immunol. 1998;101:470-474.
15. Williams PV. Treatment of rhinitis: corticosteroids and cromolyn sodium. Immun Allergy Clin North Am. 2000;20:369-381.
16. European Academy of Allergology and Clinical Immunology. Position paper: allergen standardization and skin tests. Allergy. 1993;48:S48-S82.
17. Graft D, Aaronson D, Chervinsky P, et al. A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray. J Allergy Clin Immonol. 1996;98:724-731.
18. Marazzi P, Lutsky B; the 193-133 Study Group. Prophylactic use of once-daily mometasone furoate (Nasonex) aqueous nasal spray in patients with seasonal allergic rhinitis. J Allergy Clin Immonol. 1997;99:S440.
19. Berkowitz RB, Roberson S, Zora J, et al. Mometasone furoate nasal spray is rapidly effective in the treatment of seasonal allergic rhinitis in an outdoor (park), acute exposure setting. Allergy Asthma Proc. 1999;20:167-172.
20. Ourust SV, Lamb HM. Mometasone furoate: a review of its intranasal use in allergic rhinitis. Drugs. 1998;56:725-745.
21. Berkowitz RB, Nolop RB, Mesarina-Wicky BE; c93-184 Study - Group. Onset of action of mometasone furoate (Nasonex) in the seasonal allergic rhinitis [abstract 1790]. J Allergy Clin Immunol. 1997;99:S441.
22. Rak S, Heinrich C, Jacobsen L, et al. A double-blinded, comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjuctivitis and asthma. J Allergy Clin Immunol. 2001;108:921-928.
23. Hillas J, Booth RJ, Somerfield S, et al. A comparative trial of intra-nasal beclomethasone dipropionate and sodium cromoglycate in patients with chronic perennial rhinitis. Clin Allergy. 1980;10:253-258.
24. Welsh PW, Stricker WE, Chu CP, et al. Efficacy of beclomethasone nasal solution, flunisolide, and cromolyn in relieving symptoms of ragweed allergy. Mayo Clin Proc. 1987;62:125-134.
25. Bousquet J, Chanal I, Alquié MC, et al. Prevention of pollen rhinitis symptoms: comparison of fluticasone propionate aqueous nasal spray and disodium cromoglycate aqueous nasal spray. Allergy. 1993;48:327-333.
26. Fisher WG. Comparison of budesonide and disodium cromo glycate for the treatment of seasonal allergic rhinitis in children. Ann Allergy. 1994;73:515-520.